| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.064 | 0.2 |